Zur Kurzanzeige

2011-02-16Zeitschriftenartikel DOI: 10.1186/1742-4690-8-11
Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly
dc.contributor.authorVotteler, Jörg
dc.contributor.authorNeumann, Liane
dc.contributor.authorHahn, Sabine
dc.contributor.authorHahn, Friedrich
dc.contributor.authorRauch, Pia
dc.contributor.authorSchmidt, Kerstin
dc.contributor.authorStudtrucker, Nicole
dc.contributor.authorSolbak, Sara MØ
dc.contributor.authorFossen, Torgils
dc.contributor.authorHenklein, Peter
dc.contributor.authorOtt, David E.
dc.contributor.authorHolland, Gudrun
dc.contributor.authorBannert, Norbert
dc.contributor.authorSchubert, Ulrich
dc.date.accessioned2018-05-07T14:27:55Z
dc.date.available2018-05-07T14:27:55Z
dc.date.created2011-03-07
dc.date.issued2011-02-16none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/reJeV7zaH51Yo/PDF/25U6o9wAZgjkQ.pdf
dc.identifier.urihttp://edoc.rki.de/176904/829
dc.description.abstractBackground: The HIV-1 p6 Gag protein regulates the final abscission step of nascent virions from the cell membrane by the action of two late assembly (L-) domains. Although p6 is located within one of the most polymorphic regions of the HIV-1 gag gene, the 52 amino acid peptide binds at least to two cellular budding factors (Tsg101 and ALIX), is a substrate for phosphorylation, ubiquitination, and sumoylation, and mediates the incorporation of the HIV-1 accessory protein Vpr into viral particles. As expected, known functional domains mostly overlap with several conserved residues in p6. In this study, we investigated the importance of the highly conserved serine residue at position 40, which until now has not been assigned to any known function of p6. Results: Consistently with previous data, we found that mutation of Ser-40 has no effect on ALIX mediated rescue of HIV-1 L-domain mutants. However, the only feasible S40F mutation that preserves the overlapping pol open reading frame (ORF) reduces virus replication in T-cell lines and in human lymphocyte tissue cultivated ex vivo. Most intriguingly, L-domain mediated virus release is not dependent on the integrity of Ser-40. However, the S40F mutation significantly reduces the specific infectivity of released virions. Further, it was observed that mutation of Ser-40 selectively interferes with the cleavage between capsid (CA) and the spacer peptide SP1 in Gag, without affecting cleavage of other Gag products. This deficiency in processing of CA, in consequence, led to an irregular morphology of the virus core and the formation of an electron dense extra core structure. Moreover, the defects induced by the S40F mutation in p6 can be rescued by the A1V mutation in SP1 that generally enhances processing of the CA-SP1 cleavage site. Conclusions: Overall, these data support a so far unrecognized function of p6 mediated by Ser-40 that occurs independently of the L-domain function, but selectively affects CA maturation and virus core formation, and consequently the infectivity of released virions.eng
dc.language.isoeng
dc.publisherRobert Koch-Institut, Infektionsepidemiologie
dc.subjectAmino Acid Sequenceeng
dc.subjectCell Lineeng
dc.subjectHumanseng
dc.subjectMolecular Sequence Dataeng
dc.subjectVirus Replicationeng
dc.subjectMutationeng
dc.subjectHela Cellseng
dc.subjectVirus Assemblyeng
dc.subjectVirion/ultrastructureeng
dc.subjectCells Culturedeng
dc.subjectCapsid/metabolismeng
dc.subjectGene Expression Regulation Viraleng
dc.subjectMagnetic Resonance Spectroscopyeng
dc.subjectMicroscopy Electron Transmissioneng
dc.subjectSerine/geneticseng
dc.subjectT-Lymphocyteseng
dc.subjectVirion/metabolismeng
dc.subjectVirus Releaseeng
dc.subjectgag Gene Products Human Immunodeficiency Virus/chemistryeng
dc.subjectgag Gene Products Human Immunodeficiency Virus/geneticseng
dc.subjectgag Gene Products Human Immunodeficiency Virus/metabolismeng
dc.subject.ddc610 Medizin
dc.titleHighly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10012760
dc.identifier.doi10.1186/1742-4690-8-11
dc.identifier.doihttp://dx.doi.org/10.25646/754
local.edoc.container-titleRetrovirology
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://www.retrovirology.com/content/8/1/11
local.edoc.container-publisher-nameBioMedCentral
local.edoc.container-volume8
local.edoc.container-issue1
local.edoc.container-year2011

Zur Kurzanzeige